MCI Launches New Radiation Technology

The USA Health Mitchell Cancer Institute (MCI) recently unveiled $2.5 million in advanced technology with the Elekta Versa HD, a medical linear accelerator that aims radiation at cancer cells while sparing the surrounding tissue. The new Versa HD and a similar machine at MCI’s Fairhope location are the only linear accelerators in South Alabama made by the Swedish company Elekta. Using the Versa HD, the radiation oncology team at MCI can create a 3D digital sculpture detailing how doses of radiation will be delivered to a patient’s tumor. During treatment, the patient lies on a robotic table that can be adjusted using six-dimensional repositioning. The Versa HD uses a surface-guided arm, can target very small tumors and adjusts based on a patient’s breathing. Such precision helps to spare surrounding tissue and reduces side effects for patients. One of the most common treatments for cancer, radiation therapy may be used by itself or with other treatments such as surgery, chemotherapy, hormone therapy and targeted therapy.

Read More

Mathews To Headline First Regions Arena Event

Mathews To Headline First Regions Arena Event

Moore Coming To Saenger

Moore Coming To Saenger

Buffett Exhibit To Open September 12

Buffett Exhibit To Open September 12

ADCNR Awarded $7.1 Million To Improve Oyster Resilience

ADCNR Awarded $7.1 Million To Improve Oyster Resilience

ADCNR Hunter Education Classes Coming Up

ADCNR Hunter Education Classes Coming Up

Grants Accepted For Little Dauphin Island Restoration

Grants Accepted For Little Dauphin Island Restoration

Mobile Bay Inspiration Home Tours Continue Through August 30

Mobile Bay Inspiration Home Tours Continue Through August 30

Wilkins Miller Named A Top Accounting Firm To Work For

Wilkins Miller Named A Top Accounting Firm To Work For

Keesler Federal Battleship 12k To Be Held In November

Keesler Federal Battleship 12k To Be Held In November

Subscribe to our weekly newsletter

Sign up here for free to get Bay Business News email newsletter every Friday.

By subscribing, you agree to our User Agreement and Privacy Policy & Cookie Statement.

Something went wrong. Please check your entries and try again.